Granules India honoured with Golden Peacock Award for Sustainability

Written by Ruchika Sharma Published On 2024-11-15T11:00:22+05:30 | Updated On 15 Nov 2024 11:00 AM IST

Granules India honoured with Golden Peacock Award for Sustainability

Hyderabad: Granules India Limited, a pharmaceutical company, has announced that it has received the Golden Peacock Award for Sustainability. This esteemed award was presented at the Institute of Directors’ Annual Global Convention on Corporate Governance & Sustainability being held in London, UK.

This recognition follows a highly competitive selection process with 499 applicants and a rigorous three-tier assessment. Granules India is especially honoured to be acknowledged by an esteemed jury, comprising former Chief Justices of India, the Vice-Chair of the GHG Protocol, and other prominent leaders in governance, law, and sustainability.

"This award reaffirms Granules India’s commitment to “Healing lives responsibly through pioneering green science,” as the company strives to make a positive impact at every step of its sustainability journey. Granules India is dedicated to achieving Net Zero emissions by 2050, in alignment with the Science Based Targets initiative (SBTi) and the United Nations’ Sustainable Development Goals (SDGs). Granules’ sustainability strategy emphasizes reducing Scope 1, 2, and 3 emissions, expanding renewable energy usage, and minimizing waste. These initiatives are supported by a robust governance framework led by a highly experienced Board of Directors, ensuring the highest standards of ethical conduct and transparency," the Company stated.

Dr Krishna Prasad Chigurupati, Chairman and Managing Director of Granules India Limited, commented on the award, saying, “Receiving the Golden Peacock Award for Sustainability is a proud moment for all of us at Granules. It reflects our commitment to embedding sustainability at the heart of our operations. As we strive to achieve Net Zero by 2050, our focus remains on pioneering green science and reducing our environmental impact in ways that benefit both our business and society. This recognition reaffirms our commitment to ethical governance and to advancing a responsible, sustainable future.”

Granules India Limited, incorporated in 1991 is a vertically integrated Indian pharmaceutical company headquartered in Hyderabad. Amongst the few pharmaceutical companies in the world to be present across the manufacturing of the entire pharmaceutical value chain – from Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs), Granules products are distributed to over 300+ customers in regulated and semiregulated markets with a global presence extending to over 80+ countries with offices across India, US and UK. The Company has 10 manufacturing facilities out of which 8 are located in India and 2 are in the USA and has regulatory approvals from the US FDA, EDQM, EU GMP, COFEPRIS, WHO GMP, TGA, K FDA, DEA, MCC, and HALAL.

granules indiaGolden Peacock Awardgranules news

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751